Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Frontiers in Pharmacology|March 27, 2023
Circulating tumor DNA: Opportunities and challenges for pharmacometric approachesBenjamin Ribba, Andreas Roller, Hans-Joachim Helms, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 23, 2014
Parameterizing cell-to-cell regulatory heterogeneities via stochastic transcriptional profilesSameer S Bajikar, Christiane Fuchs, Andreas Roller, et al.
Clinical Pharmacology and Therapeutics|November 17, 2023
Matching by OS Prognostic Score to Construct External Controls in Lung Cancer Clinical TrialsHugo Loureiro, Andreas Roller, Meike Schneider, et al.
Immunogenetics|December 20, 2018
The genomic organization and expression pattern of the low-affinity Fc gamma receptors (FcγR) in the Göttingen minipigJerome Egli, Roland Schmucki, Benjamin Loos, et al.
Plos One|February 6, 2013
Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 casesAnnette Fasan, Tamara Alpermann, Claudia Haferlach, et al.
The Journal of Molecular Diagnostics : JMD|May 18, 2013
Robustness of amplicon deep sequencing underlines its utility in clinical applicationsVera Grossmann, Andreas Roller, Hans-Ulrich Klein, et al.
Genes, Chromosomes & Cancer|January 24, 2013
The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALLVera Grossmann, Claudia Haferlach, Sandra Weissmann, et al.
British Journal of Haematology|March 26, 2013
CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosisVera Grossmann, Claudia Haferlach, Niroshan Nadarajah, et al.
British Journal of Haematology|December 31, 2013
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impactUlrike Bacher, Torsten Haferlach, Susanne Schnittger, et al.
Blood|August 25, 2012
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)Manja Meggendorfer, Andreas Roller, Torsten Haferlach, et al.
Pageof 3